Pediatric hydrocephalus and geriatric hydrocephalus are two types of hydrocephalus that are commonly seen in cerebrospinal fluid department clinics. According to statistics, the incidence rate of pediatric hydrocephalus is 0.3%~0.5%. Behind such a huge figure is the heartache of countless children and families. The incidence of normal pressure hydrocephalus in China is not yet known, however, from the overall viewpoint of clinically diagnosed cases, there are not many people suffering from the disease. Patients with normal pressure hydrocephalus have three typical symptoms: physical impairment, cognitive dysfunction, and urinary impairment. The disease generally develops progressively, and in the early stage patients will show obvious symptoms such as memory loss, delayed thinking, unstable walking and easy falling. When the elderly have unexplained slow walking imbalance, it is likely that they are suffering from normal pressure hydrocephalus. Normal pressure hydrocephalus has an obvious incidence group, that is, elderly people who are older than 65 years old. This stage of the elderly is older and some of them also suffer from multiple diseases, so it is difficult to treat. So, how long can 70 elderly people live with hydrocephalus under conservative treatment? In modern medicine, the treatment of hydrocephalus is usually based on shunt surgery, supplemented by medication. most elderly people over 70 years old suffer from normal pressure hydrocephalus, and conservative treatment mainly takes medication, which is difficult to achieve the desired effect, and may be life-threatening if the condition is allowed to develop. In contrast, if surgery is performed in a timely manner and the patient actively cooperates with the doctor, it is still possible to regain recovery and has little impact on life expectancy. In the treatment of cerebrospinal fluid disorders, the complication rate of shunt surgery is high, mainly including infection, shunt blockage, and shunt fracture. Common infections include intracranial infection, incisional infection, shunt subcutaneous channel infection, etc. These complications can lead to serious consequences if not handled in a timely manner or improperly disposed of. In response to this situation, the Department of Cerebrospinal Fluid has developed a set of “Cerebrospinal Fluid Specialized Technology” over the years, which can effectively treat all kinds of hydrocephalus, and has a set of systematic and complete targeted solutions for post-shunt infection, blockage of shunts and other complications, bringing the treatment of hydrocephalus to a new level.